BackPTC Therapeutics Overview

PTC Therapeutics Profit Margin

Valuation check: PTCT's profit margin is -9.17%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-14.45%
↓ 291.77% YoY

As of Sep 2026

Annual Profit Margin (TTM)

-9.17%
↓ 121.70% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

PTC Therapeutics (PTCT) FAQ

As of the most recent data (September 2026), PTCT shows a profit margin of -9.17%. That compares with 42.25% in the prior-year period — down 121.7% year over year. That is below the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTCT's profit margin is now -9.17% (was 42.25%) — a 121.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PTC Therapeutics is outperforming or lagging.

The Healthcare sector average profit margin is about 17.63%. PTC Therapeutics is at -9.17%, which is lower that average. That is roughly 152.0% below the sector mean. Use the comparison chart on this page to see how PTCT stacks up against individual peers as well.

That compares with 42.25% in the prior-year period — down 121.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare PTC Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has PTC Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -9.17%) with ownership activity and broader fundamentals.